Biogen CEO Plots A Slow Return To Growth As Revenue Set To Shrink Again In 2023

Cost Cuts, R&D Prioritization, Deals All On The Table

 
• By Mandy Jackson
Q4 on red background, fourth quarter cover or poster
Biogen reported a 7% revenue decline for Q4 and the full year of 2022 • Source: Shutterstock

More from New Products

More from Scrip